Promising Mpox Drug Fails in Trials as Virus Spreads
In a trial in the Democratic Republic of the Congo, the drug tecovirimat, also known as TPOXX, was found to be no better than placebo at clearing mpox lesions.
In a trial in the Democratic Republic of the Congo, the drug tecovirimat, also known as TPOXX, was found to be no better than placebo at clearing mpox lesions.
Hemanth Kumar Gorle
Mr. Hemanth Kumar Gorle, founder of Indian Web Services, specializes in web development, hosting, and online marketing. He is dedicated to creating effective digital solutions and fostering successful business relationships through his expertise and strategic approach.
This website uses cookies to enhance your browsing experience. By continuing to use this site, you consent to the use of cookies. Please review our Privacy Policy for more information on how we handle your data.